April 21, 2011 /PRNewswire/ -- Tibet Pharmaceuticals, Inc. (NASDAQ: TBET), an emerging specialty pharmaceutical company engaged in the development, manufacturing and marketing of traditional Tibetan medicine in
China, today released an online corporate overview video.
The in-depth video provides a concise overview of Tibet Pharmaceuticals' specialty medicines and growth opportunity in
China's expanding healthcare industry, and is a great resource for both existing shareholders and prospective investors alike.
The video is available at:
From the corporate overview video: "With the growing purchasing power of
's 1.3 billion citizens, the market for these Tibetan medicines is estimated to be increasing at a rate of 50% annually, or 3 times the growth rate of overall healthcare spending in
The video goes on to state: "Tibet Pharmaceuticals is a rapidly growing and profitable pharmaceutical company capitalizing on the expanding healthcare markets in China… In 2010, Tibet's audited financial results showed strong increases of sales to
in net income. The company's sales have grown by double digit rates year-over-year, all while maintaining margins in excess of 30 to 40%."
The overview video is the first of a series of informative videos to be released that will discuss Tibet Pharmaceuticals, its specialty medicines and aggressive growth plans as well as its ongoing mandate to add significant and consistent shareholder value.
About Tibet Pharmaceuticals, Inc.
Based in Shangri-La County,
, Tibet Pharmaceuticals, Inc. (NASDAQ: TBET) is a rapidly growing specialty pharmaceutical company engaged in the research, development, manufacturing and marketing of modernized traditional Tibetan medicines in
. With over 190 full-time employees and nation-wide distributors, the company develops both prescription and over-the-counter traditional Tibetan medicines that promote health in human respiratory, digestive, urinary and reproductive systems. Tibet Pharmaceuticals' products are sold throughout
, with a majority of sales concentrated in the southern provinces, most notably
, where the company's 52,000 sq. ft. GMP-certified manufacturing facilities are located. The access to key raw materials, not generally available outside the province, provides a significant advantage for Tibet Pharmaceuticals.
For more information on Tibet Pharmaceuticals, please visit: